Insulin aspart, recombinant Subcutaneous and Novoeight recombinant
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Novolin 70/30
- Insulin aspart, recombinant Subcutaneous-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Insulin aspart, recombinant Subcutaneous-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Insulin aspart, recombinant Subcutaneous-Novolin N
- Insulin aspart, recombinant Subcutaneous-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Insulin aspart, recombinant Subcutaneous-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Insulin degludec
- Novoeight recombinant-Insulin Degludec (U-100) Prefilled Pens
- Novoeight recombinant-Insulin Degludec (U-100) Vials
- Novoeight recombinant-Insulin Degludec (U-200) Prefilled Pens
- Novoeight recombinant-Insulin degludec and liraglutide
- Novoeight recombinant-Insulin degludec and liraglutide Subcutaneous